Dramatic erythroid response to low‐dose thalidomide in two patients with transfusion independent thalassemia and severe post‐transfusional alloimmune hemolysis

Dombret H. Results of a phase 3, multicenter, randomized, open-label study of azacytidine versus conventional care regimens in olders patients with newly diagnosed acute myeloid leukemia.EHA Annual Meeting Abstracts 2014:LB-6212.11.Kantarjian HM, Thomas XG, Dmoszynska A, et al.Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.